Stem Cell and Regenerative Medicine Section, Developmental Biology and Cancer Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom; Specialist Neonatal and Paediatric Surgery Unit, Great Ormond Street Hospital, London, United Kingdom.
Stem Cell and Regenerative Medicine Section, Developmental Biology and Cancer Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Best Pract Res Clin Gastroenterol. 2022 Feb-Mar;56-57:101769. doi: 10.1016/j.bpg.2021.101769. Epub 2021 Oct 30.
Several paediatric gastrointestinal diseases result in life-shortening organ failure. For many of these conditions, current therapeutic options are suboptimal and may not offer a cure. Regenerative medicine is an inter-disciplinary field involving biologists, engineers, and clinicians that aims to produce cell and tissue-based therapies to overcome organ failure. Exciting advances in stem cell biology, materials science, and bioengineering bring engineered gastrointestinal cell and tissue therapies to the verge of clinical trial. In this review, we summarise the requirements for bioengineered therapies, the possible sources of the various cellular and non-cellular components, and the progress towards clinical translation of oesophageal and intestinal tissue engineering to date.
一些儿科胃肠疾病会导致危及生命的器官衰竭。对于许多此类疾病,目前的治疗选择并不理想,可能无法治愈。再生医学是一个涉及生物学家、工程师和临床医生的跨学科领域,旨在开发基于细胞和组织的疗法以克服器官衰竭。干细胞生物学、材料科学和生物工程的令人兴奋的进步使工程化胃肠细胞和组织疗法接近临床试验阶段。在这篇综述中,我们总结了生物工程疗法的要求,各种细胞和非细胞成分的可能来源,以及迄今为止食管和肠道组织工程向临床转化的进展。